Echo Street Capital Management LLC Moderna, Inc. Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $114,173 - $187,772	967 Added 53.16%	2,786 $329,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $213,059 - $321,217	1,819 New	1,819 $260,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $511,910 - $951,482	-4,048 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $788,789 - $1.29 Million	3,493 Added 629.37%	4,048 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $107,177 - $233,999	-483 Reduced 46.53%	555 $214,000
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $109,124 - $197,383	-840 Reduced 44.73%	1,038 $244,000
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $205,040 - $349,270	1,878 New	1,878 $246,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.